Gene · 3148
Papers1,965
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,965
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HMGB1 promotes Ox-LDL-induced endothelial cell damage by inhibiting PI3K/Akt signaling pathway. | BMC Cardiovasc Disord | 2022 | 36544080 | PubTator, text mining | PubMed |
| Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis. | Cell Rep Med | 2022 | 36543113 | PubTator, text mining | PubMed |
| Pivotal role of High-Mobility Group Box 2 in ovarian folliculogenesis and fertility. | J Ovarian Res | 2022 | 36539852 | PubTator, text mining | PubMed |
| A phylogenetic review of cancer resistance highlights evolutionary solutions to Peto's Paradox. | Genet Mol Biol | 2022 | 36534348 | PubTator, text mining | PubMed |
| Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. | J Transl Med | 2022 | 36528667 | PubTator, text mining | PubMed |
| MiR-193-3p inhibits the malignant progression of atherosclerosis by targeting WDR5. | Clin Appl Thromb Hemost | 2022 | 36523143 | PubTator, text mining | PubMed |
| Microbiota-host crosstalk in the newborn and adult rumen at single-cell resolution. | BMC Biol | 2022 | 36514051 | PubTator, text mining | PubMed |
| PfHMGB2 has a role in malaria parasite mosquito infection. | Front Cell Infect Microbiol | 2022 | 36506024 | PubTator, text mining | PubMed |
| Low-Intensity Pulsed Ultrasound Counteracts Advanced Glycation End Products-Induced Corpus Cavernosal Endothelial Cell Dysfunction via Activating Mitophagy. | Int J Mol Sci | 2022 | 36499213 | PubTator, text mining | PubMed |
| Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patients. | Commun Med (Lond) | 2022 | 36496530 | PubTator, text mining | PubMed |
| The emerging role of epigenetic regulation in the progression of silicosis. | Clin Epigenetics | 2022 | 36494831 | PubTator, text mining | PubMed |
| Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa. | Front Immunol | 2022 | 36479111 | PubTator, text mining | PubMed |
| The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma. | Front Cell Dev Biol | 2022 | 36467404 | PubTator, text mining | PubMed |
| Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor. | Am J Hum Genet | 2022 | 36459980 | PubTator, text mining | PubMed |
| The identification and preliminary study of lncRNA TUG1 and its related genes in hepatocellular carcinoma. | Arch Med Sci | 2022 | 36457956 | PubTator, text mining | PubMed |
| The regulatory activities of MALAT1 in the development of bone and cartilage diseases. | Front Endocrinol (Lausanne) | 2022 | 36452326 | PubTator, text mining | PubMed |
| Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes. | Nat Commun | 2022 | 36443294 | PubTator, text mining | PubMed |
| Single-cell transcriptomic characterization reveals the landscape of airway remodeling and inflammation in a cynomolgus monkey model of asthma. | Front Immunol | 2022 | 36439114 | PubTator, text mining | PubMed |
| PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma. | Cell Commun Signal | 2022 | 36434616 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Cartilage Repair and Their Possible Clinical Uses: A Review of Recent Developments. | Int J Mol Sci | 2022 | 36430749 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3148/papers?page=19